Rush MD Anderson Cancer Center at Rush Lisle is a clinical research site located in Lisle, Illinois, United States 60532.
Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.
Rush MD Anderson Cancer Center at Rush Lisle has participated in 6 clinical trials with 5 currently active.
Therapeutic areas: Stage III Colon Cancer, B Acute Lymphoblastic Leukemia, Previously Treated Non-Small Cell Lung Cancer.
Sponsors: NRG Oncology, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.
Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rush MD Anderson Cancer Center at Rush Lisle has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush MD Anderson Cancer Center at Rush Lisle has 6 clinical trials on record, with 5 currently active. Their work covers Stage III Colon Cancer, B Acute Lymphoblastic Leukemia, Previously Treated Non-Small Cell Lung Cancer.
Rush MD Anderson Cancer Center at Rush Lisle has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.